Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Moodys
McKinsey
Express Scripts
Merck
Baxter
AstraZeneca

Last Updated: January 17, 2020

DrugPatentWatch Database Preview

Trovafloxacin mesylate - Generic Drug Details

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What are the generic drug sources for trovafloxacin mesylate and what is the scope of patent protection?

Trovafloxacin mesylate is the generic ingredient in one branded drug marketed by Pfizer and is included in one NDA. Additional information is available in the individual branded drug profile pages.

Summary for trovafloxacin mesylate
US Patents:0
Tradenames:1
Applicants:1
NDAs:1
Bulk Api Vendors: 28
Patent Applications: 699
DailyMed Link:trovafloxacin mesylate at DailyMed
Synonyms for trovafloxacin mesylate
(1|A,5|A,6|A)-7-(6-Amino-3-azabicyclo[3.1.0]hex-3-yl)-1-(2,4-difluorophenyl)-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid methanesulfonate
(1alpha,5alpha,6alpha)-7-(6-Amino-3-azabicyclo[3.1.0]hex-3-yl)-1-(2,4-difluorophenyl)-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid methanesulfonate
(1R,5S,6s)-3-[6-carboxy-8-(2,4-difluorophenyl)-3-fluoro-5-oxo-5,8-dihydro-1,8-naphthyridin-2-yl]-3-azabicyclo[3.1.0]hexan-6-aminium methanesulfonate
0P1LKO80WN
1,8-Naphthyridine-3-carboxylic acid, 1,4-dihydro-7-(6-amino-3-azabicyclo(3.1.0)hex-3-yl)-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-, (1alpha,5alpha,6alpha)-, monomethanesulfonate
1,8-Naphthyridine-3-carboxylic acid, 7-(6-amino-3-azabicyclo(3.1.0)hex-3-yl)-1-(2,4-difluorophenyl)-6-fluoro-1,4-dihydro-4-oxo-(1alpha,5alpha,6alpha)-, monomethanesulfonate
147059-75-4
7-((1R,5S,6s)-6-Amino-3-azabicyclo(3.1.0)hex-3-yl)-1-(2,4-difluorophenyl)-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid, monomethanesulfonate
7-[(1?,5?,6?)-6-Amino-3-azabicyclo[3.1.0]hex-3-yl]-1-(2,4-difluorophenyl)-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid mesylate
7-[(1|A,5|A,6|A)-6-Amino-3-azabicyclo[3.1.0]hex-3-yl]-1-(2,4-difluorophenyl)-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic Acid Methanesulfonate
7-[(1R,5S,6s)-6-amino-3-azabicyclo[3.1.0]hex-3-yl]-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid methanesulfonate
7-[(1r,5s)-6-amino-3-azabicyclo[3.1.0]hex-3-yl]-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid methanesulfonate(1:1)
7-[(1S,5R)-6-amino-3-azabicyclo[3.1.0]hexan-3-yl]-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid; methanesulfonic acid
AC1L1Y47
AC1Q6WCM
AKOS000280396
AKOS015914051
API0008271
C20H15F3N4O3.CH4O3S
CAS-147059-75-4
CCG-221411
CHEBI:77568
CHEMBL1200779
CP 99219
CP 99219 mesylate
CP 99219-27
CP-99,219-27
CP-99219
CP-99219-27
CP-9921927
D02123
DSSTox_CID_25701
DSSTox_GSID_45701
DSSTox_RID_81073
DTXSID0045701
DYNZICQDCVYXFW-AHZSKCOESA-N
DYNZICQDCVYXFW-GIPYJWDTSA-N
FT-0675705
HMS3260E16
I14-44539
J-008308
J-690188
LS-95905
MFCD00913361
MolPort-005-935-608
NCGC00064532-02
NCGC00260792-01
NCGC00263538-01
SCHEMBL40874
SCHEMBL40875
Tox21_110980
Tox21_110980_1
Tox21_500107
Trovafloxacin mesilate
Trovafloxacin mesylate (USAN)
Trovafloxacin mesylate [USAN]
Trovafloxacin mesylate, >98% (HPLC)
Trovafloxacin methanesulfonate
trovafloxacin monomesylate
Trovafloxacin monomethanesulfonate
Trovafloxacin sulfate
Trovan
Trovan (TN)
Turvel
UNII-0P1LKO80WN
X2013

US Patents and Regulatory Information for trovafloxacin mesylate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pfizer TROVAN trovafloxacin mesylate TABLET;ORAL 020759-001 Dec 18, 1997 DISCN No No   Start Trial   Start Trial   Start Trial
Pfizer TROVAN trovafloxacin mesylate TABLET;ORAL 020759-002 Dec 18, 1997 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for trovafloxacin mesylate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pfizer TROVAN trovafloxacin mesylate TABLET;ORAL 020759-002 Dec 18, 1997   Start Trial   Start Trial
Pfizer TROVAN trovafloxacin mesylate TABLET;ORAL 020759-001 Dec 18, 1997   Start Trial   Start Trial
Pfizer TROVAN trovafloxacin mesylate TABLET;ORAL 020759-001 Dec 18, 1997   Start Trial   Start Trial
Pfizer TROVAN trovafloxacin mesylate TABLET;ORAL 020759-002 Dec 18, 1997   Start Trial   Start Trial
Pfizer TROVAN trovafloxacin mesylate TABLET;ORAL 020759-002 Dec 18, 1997   Start Trial   Start Trial
Pfizer TROVAN trovafloxacin mesylate TABLET;ORAL 020759-001 Dec 18, 1997   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Express Scripts
McKesson
Colorcon
Merck
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.